We are live on ! Find out more
AIIC

AJU IB Investment Company Portfolio holdings

AUM $30.5M
1-Year Est. Return 128.96%
This Fund
S&P 500
This Quarter Est. Return
+67.27%
1 Year Est. Return
+128.96%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$30.5M
AUM Growth
+$7.74M
Cap. Flow
-$421K
Cap. Flow %
-1.38%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RAPT
RAPT Therapeutics
RAPT
+$421K
2
XLO icon
Xilio Therapeutics
XLO
+$8
3
RLYB icon
Rallybio
RLYB
+$7

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACLX
1
DELISTED
Arcellx
ACLX
$25.7M 84.07%
223,486
– –
KYMR icon
2
Kymera Therapeutics
KYMR
$9.08B
$1.64M 5.36%
19,648
– –
SEER icon
3
Seer Inc
SEER
$113M
$1.54M 5.06%
816,375
– –
RLYB icon
4
Rallybio
RLYB
$87M
$846K 2.77%
94,334
-1
-0% -$7
STRO icon
5
Sutro Biopharma
STRO
$391M
$436K 1.43%
17,500
– –
XLO icon
6
Xilio Therapeutics
XLO
$54.6M
$401K 1.31%
47,695
-1
-0% -$8
RAPT
7
DELISTED
RAPT Therapeutics
RAPT
– –
-12,437
Closed -$421K

Similar funds

LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
OGC
One68 Global Capital New York $30.9M AUM
AC
ASB Consultores Aventura, Florida $30.1M AUM 22.96% 1-Year Est. Return
PL
Protective Life Birmingham, Alabama $30.1M AUM 0.65% 1-Year Est. Return
IACCGIA
IDG-Accel China Capital GP II Associates Hong Kong $29.8M AUM
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return

AJU IB Investment Company's Q1 2026 Portfolio in Review

As of Q1 2026, AJU IB Investment Company held 7 positions worth $30.5M, up 34% from $22.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

AJU IB Investment Company's Q1 2026 filing shows 2 reduced and 1 closed positions. The largest sale was RAPT Therapeutics, an estimated $421K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • AJU IB Investment Company's biggest Q1 2026 reduction was Xilio Therapeutics, cutting an estimated $8.
  • AJU IB Investment Company fully exited RAPT Therapeutics in Q1 2026, selling an estimated $421K.
  • AJU IB Investment Company's ten largest holdings make up 100% of its $30.5M portfolio in Q1 2026.
  • AJU IB Investment Company opened 0 new positions and closed 1 in Q1 2026.
  • AJU IB Investment Company's portfolio value rose 34% quarter-over-quarter to $30.5M.

Based on AJU IB Investment Company's 13F filing for Q1 2026, filed 8 May 2026.